GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXC8 | hg19_v2_chr12_+_54402790_54402832 | -0.34 | 1.8e-07 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrX_-_109590174 Show fit | 24.44 |
ENST00000372054.1
|
guanine nucleotide binding protein (G protein), gamma 5 pseudogene 2 |
|
chr8_-_27695552 Show fit | 22.95 |
ENST00000522944.1
ENST00000301905.4 |
PDZ binding kinase |
|
chrX_+_119737806 Show fit | 18.79 |
ENST00000371317.5
|
malignant T cell amplified sequence 1 |
|
chr3_-_64009658 Show fit | 15.72 |
ENST00000394431.2
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 6 |
|
chr18_+_657578 Show fit | 15.41 |
ENST00000323274.10
|
thymidylate synthetase |
|
chr16_-_46655538 Show fit | 15.26 |
ENST00000303383.3
|
SHC SH2-domain binding protein 1 |
|
chr5_+_159848854 Show fit | 14.55 |
ENST00000517480.1
ENST00000520452.1 ENST00000393964.1 |
pituitary tumor-transforming 1 |
|
chr2_-_89292422 Show fit | 13.81 |
ENST00000495489.1
|
immunoglobulin kappa variable 1-8 |
|
chr2_+_89890533 Show fit | 13.37 |
ENST00000429992.2
|
immunoglobulin kappa variable 2D-40 |
|
chr5_+_135385202 Show fit | 13.28 |
ENST00000514554.1
|
transforming growth factor, beta-induced, 68kDa |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 233.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.5 | 77.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.5 | 56.6 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.4 | 47.9 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.8 | 37.1 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.8 | 36.8 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.6 | 32.3 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
3.5 | 24.6 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
2.4 | 23.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
3.6 | 21.5 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 97.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.7 | 54.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.3 | 48.8 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 48.6 | GO:0005615 | extracellular space(GO:0005615) |
1.3 | 40.5 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.2 | 33.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 25.9 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
4.6 | 22.8 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
2.8 | 22.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.4 | 22.2 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 208.4 | GO:0003823 | antigen binding(GO:0003823) |
1.8 | 97.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.3 | 67.5 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.5 | 33.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 28.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.1 | 25.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 24.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.8 | 23.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 23.6 | GO:0032947 | protein complex scaffold(GO:0032947) |
2.3 | 23.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 46.3 | PID AURORA B PATHWAY | Aurora B signaling |
0.3 | 39.0 | PID E2F PATHWAY | E2F transcription factor network |
1.6 | 22.8 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.5 | 21.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.6 | 21.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.3 | 17.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 17.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 16.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 15.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 14.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 82.2 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.6 | 44.5 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.7 | 42.3 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.4 | 41.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.1 | 29.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.7 | 24.3 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.9 | 23.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 23.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.6 | 22.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
1.2 | 22.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |